Sanofi SA (ADR) news

   Watch this stock
Showing stories 1 - 4 of about 4   

Articles published

SNY 46.62 +0.57 (1.24%)
price chart
Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd - claiming intent
�the primary judge's construction gives the claim a field of operation, and Sanofi-Aventis a resulting exclusive right under s 13 of the Patents Act, that exceeds the description of the invention in the body of the specification.
Related articles »  
Three Impressive Small Cap Dividend ETFs
Due to risk in the market and extreme stock volatility over the past few years, many investors seek more stability in their portfolios along with high levels of current income.
Related articles »  
3 Multi-asset ETFs for Juicy Yields and Stability
CVY follows the Zacks Multi-Asset Income Index, which is comprised of approximately 125 to 150 securities selected using a proprietary methodology, from a universe of domestic stocks, ADRs, REITs, MLPs, CEFs and preferred stocks. The objective of the ...
Related articles »  
Major Changes Made To Buffett & Berkshire Hathaway Stakes
Sanofi-Aventis (NYSE: SNY) was 4.06 million shares; SAME AS before. Torchmark Corp. (NYSE: TMK) was more than 4.2 million, SAME AS last quarter after having been raised in a prior quarter.
Related articles »